{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "20426456", "DateCompleted": {"Year": "2010", "Month": "06", "Day": "25"}, "DateRevised": {"Year": "2010", "Month": "05", "Day": "28"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1021/np100009j"], "Journal": {"ISSN": "1520-6025", "JournalIssue": {"Volume": "73", "Issue": "5", "PubDate": {"Year": "2010", "Month": "May", "Day": "28"}}, "Title": "Journal of natural products", "ISOAbbreviation": "J Nat Prod"}, "ArticleTitle": "Hasubanan alkaloids with delta-opioid binding affinity from the aerial parts of Stephania japonica.", "Pagination": {"StartPage": "988", "EndPage": "991", "MedlinePgn": "988-91"}, "Abstract": {"AbstractText": ["Two new (1 and 2) and six known hasubanan alkaloids (3-8) and one morphinane alkaloid (9) were isolated from the leaves of the North Queensland rainforest vine Stephania japonica. The structures of 1 and 2 were determined by interpretation of their 1D and 2D NMR spectra. The hasubanan alkaloids showed affinity for the human delta-opioid receptor with IC(50) values ranging from 0.7 to 46 microM. The compounds were also tested for their affinity to micro- and kappa-opioid receptors and shown to be inactive against kappa-opioid receptors, but were of similar potency against the micro-opioid receptor."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Eskitis Institute, Griffith University, Brisbane, Queensland 4111, Australia."}], "Identifier": [], "LastName": "Carroll", "ForeName": "Anthony R", "Initials": "AR"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Arumugan", "ForeName": "Thirumavalavan", "Initials": "T"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Redburn", "ForeName": "Joanne", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ngo", "ForeName": "Ana", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Guymer", "ForeName": "Gordon P", "Initials": "GP"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Forster", "ForeName": "Paul I", "Initials": "PI"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Quinn", "ForeName": "Ronald J", "Initials": "RJ"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Nat Prod", "NlmUniqueID": "7906882", "ISSNLinking": "0163-3864"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "6-cinnamoylhernandine"}, {"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "N-methylstephisoferulin"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Opioid, delta"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Opioid, kappa"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Alkaloids"}, {"QualifierName": [], "DescriptorName": "Australia"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Inhibitory Concentration 50"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Receptors, Opioid, delta"}, {"QualifierName": ["metabolism"], "DescriptorName": "Receptors, Opioid, kappa"}, {"QualifierName": ["chemistry"], "DescriptorName": "Stephania"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2010", "Month": "4", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "4", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "6", "Day": "26", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["20426456", "10.1021/np100009j"]}}], "PubmedBookArticle": []}